HHS NIH
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) is a funding opportunity from HHS NIH, closing April 6, 2027.
Overview
The NIH SBIR Phase IIB Strategic Breakthrough NOFO provides previous Phase II recipients support to bridge the gap between Phase II and commercialization, requiring 100% third-party matching funds from new private capital or government agencies. Applications are encouraged for projects with strong commercial potential…